Melissa Berry interviews Dr. Darren Tayama, Vice President, US Medical Affairs Oncology at Gilead Sciences about Gilead's approach to advancing oncology care, particularly insights on treating triple negative breast cancer and the role of novel therapies in improving patient outcomes.